Flamel will use its Medusa nanogel polymer and Micropump microencapsulation drug delivery technologies to develop new formulations of three Digna compounds

Flamel Technologies S.A.

France / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Digna Biotech S.L.

Spain / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced